Vaccines designed to prevent cholera caused by Vibrio cholerae, supplied by manufacturers to public health programs, hospitals, clinics, and humanitarian operations. Buyers include government health agencies, international organizations, NGOs, and pharmaceutical distributors procuring immunization campaigns and routine vaccination stock.